Pheophorbide a isolated from Gelidium amansii inhibits adipogenesis by down-regulating adipogenic transcription factors in 3T3-L1 adipocytes

Visit for more related articles at Journal of Pharmacy Practice and Education

Abstract

Background: Adipocyte lipid accumulation causes adipocyte hypertrophy and adipose tissue increment, leading to obesity. Thus, this study investigated the anti-adipogenic effects of pheophorbide A isolated from Gelidium amansii in 3T3-L1 adipocytes. Methods: Upon differentiation of 3T3-L1 pre-adipocytes into adipocytes, they were treated with pheophorbide A. Results: Pheophorbide a inhibited triglyceride accumulation and stimulated glycerol release in a dose-dependent manner in 3T3- L1 adipocytes. In addition, pheophorbide A significantly decreased leptin levels in 3T3-L1 adipocytes. Pheophorbide A inhibited adipogenesis via suppression of the expression of adipogenic transcriptional factors including peroxisome proliferator-activated receptor enhancer binding protein sterol regulatory element binding protein 1c (SREBP1c), and fatty acid synthase (FAS). It also induced the expression of phosphorylation of AMP-activated protein kinase (AMPK). Conclusion: Pheophorbide A isolated from Gelidium amansii inhibit adipogenesis by down-regulating adipogenic transcription factors in 3T3-L1 adipocytes. These results suggest that pheophorbide A may be useful for the prevention or treatment of obesity owing to its inhibitory effect on adipogenesis.

Select your language of interest to view the total content in your interested language

Viewing options

Flyer image

Share This Article